Key result
Simultaneous TAVR and EVAR demonstrates feasibility with good 6-month valve function in severe aortic disease.
Why the study?
Concomitant severe aortic stenosis and abdominal aortic aneurysm in elderly patients presents a significant therapeutic challenge, and simultaneous management of both conditions with TAVR and EVAR remains rare.
Case Report (n=1)
No
Simultaneous TAVR and EVAR is a feasible and safe treatment strategy for high-risk elderly patients with coexisting severe aortic stenosis and abdominal aortic aneurysm.
Supports feasibility of simultaneous TAVR-EVAR in select high-risk patients; leaves open need for prospective trials before broader adoption.
Background and Clinical Significance: Concomitant severe aortic stenosis (AS) and abdominal aortic aneurysm (AAA) in elderly patients presents a significant therapeutic challenge. While transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR) have become established minimally invasive treatments for high-risk patients, simultaneous management of both conditions remains rare. Case Presentation: We report the first documented case in Serbia of a simultaneous TAVR and EVAR in a 75-year-old male with severe symptomatic AS and AAA. The patient had a history of hypertension, diabetes mellitus, atrial fibrillation, prior radiofrequency pulmonary vein ablation, and pacemaker implantation. Echocardiography demonstrated severe AS with a transvalvular gradient of 116/61 mmHg, an aortic valve area of 0.6 cm2, and a left ventricular ejection fraction of 30–35%. Coronary angiography revealed 50–60% stenosis of the right coronary artery. Following evaluation by a multidisciplinary Heart and Vascular Team, a combined procedure was performed under general anesthesia via bilateral femoral access. TAVR with a Medtronic Evolut R valve was successfully deployed, followed by EVAR with satisfactory stent graft positioning and angiographic results. The patient’s postoperative course was uneventful, and he was discharged on the ninth day. At six-month follow-up, echocardiography showed optimal valve function, and CT identified a type II endoleak, which was managed conservatively. Conclusions: This case demonstrates the feasibility and safety of simultaneous TAVR and EVAR in a high-risk elderly patient, emphasizing the importance of careful preoperative planning and a coordinated multidisciplinary approach. Further studies are warranted to establish standardized guidelines for the management of patients with coexisting severe AS and AAA.
No takes yet. Share an insight, caveat, or question.
Boljević et al. (2025) conducted a case report in Severe aortic stenosis and abdominal aortic aneurysm (n=1). Simultaneous TAVR and EVAR was evaluated. Simultaneous TAVR and EVAR was successfully performed in a 75-year-old male with severe aortic stenosis and abdominal aortic aneurysm, with optimal valve function at 6-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: